HJ

Hassan Jauwad

Active Director Director DIN 08153820
DIN 08153820 First appointment Jun 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2018
Shareholding value •••• Premium profile

About Hassan Jauwad

Data last updated:

Hassan Jauwad is a Director at Nobility Pharmaceutical Private Limited (since 2018). The company operates in Pharma. Nobility Pharmaceutical Private Limited reported revenue of ₹18 Lakh (FY 2020).

DIN 08153820
Primary Designation Director
Industry Pharma
First Appointment 09 Jun 2018
Oldest Company Age 8 yrs
Largest company Nobility Pharmaceutical Private Limited · ₹18 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Jun 20182018₹18 Lakh (FY 2020)Active

Board colleagues of Hassan Jauwad

Directorship timeline

Open interactive timeline →
Nobility Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Hassan Jauwad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hassan Jauwad

Hassan Jauwad currently holds 1 directorship: Nobility Pharmaceutical Private Limited (Director, since 09 Jun 2018, revenue ₹18 Lakh (FY 2020)).

Hassan Jauwad was first appointed on 09 Jun 2018 as Director at Nobility Pharmaceutical Private Limited.

The current boards of Hassan Jauwad's companies include Ambar Abidi (Nobility Pharmaceutical Private Limited), Dinesh Singh (Nobility Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available